Class IITerminatedD-0218-2018
Drug recall · January 24, 2018
Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ recall
Why: GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, NDC 58411-256-60
- Lots / codes
SKU#: 95284
- Quantity
- N/A
- Company
- Shiseido America Inc., East Windsor, NJ
- Distribution
- Product was distributed nationwide.
- Initiated
- December 14, 2017 · Voluntary: Firm initiated
- Classified
- January 12, 2018
- Reported
- January 24, 2018
- Ended
- June 24, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJan 24, 2018bareMinerals Broad Spectrum SPF 50 Daily Prep LotionShiseido America Inc. · D-0214-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Universal Defense SPF 50+Shiseido America Inc. · D-0215-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Discovery Set contains SPF 50+Shiseido America Inc. · D-0216-2018Class IITerminatedJan 24, 2018Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+Shiseido America Inc. · D-0217-2018
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.